About ILCA

Who are we?
The International Liver Cancer Association (ILCA) is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines.

Mission
The International Liver Cancer Association (ILCA) aspires towards advancing research in the pathogenesis, prevention, and treatment of liver cancer.

The International Liver Cancer Association (ILCA) will do so by promoting novel pathogenic, diagnostic and therapeutic interventions for liver cancer by taking a transversal approach to research and bringing together scientists, physicians and allied professionals from all interrelated fields.

Goals
The International Liver Cancer Association (ILCA):

• Is committed to promoting basic, clinical, translational, multi-disciplinary and multi-national liver cancer research, including the development of clinical trials
• Fosters, encourages and facilitates scientific exchange and dissemination of knowledge
• Strives to educate physicians, scientists, allied healthcare professionals and the general public at large
• Will educate international and national health authorities on the diagnosis, prevention and management of liver cancer
• Values collaboration with other learned societies, governmental organisations, professional associations, groups, institutions and individuals who contribute to progress in the field

ILCA membership
The International Liver Cancer Association (ILCA) invites clinical, translational and basic researchers, physicians and allied professionals from around the world in all disciplines involved in liver cancer -- epidemiology, gastroenterology, hepatology, internal medicine, molecular biology, (interventional) oncology, pathology, (interventional) radiology, and surgery/transplantation -- to join and participate in ILCA activities.

ILCA currently counts members in 35 countries and is growing rapidly as the association and its meetings are attracting professionals that share our organisation's aim to increase the understanding of liver cancer and develop treatments that offer true hope for patients affected by the disease.

ILCA members receive a significant discount on the ILCA 2010 registration fee. To apply for membership, please contact the ILCA Office.

For more information on ILCA, visit www.ilca-online.org